Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH).
Open Access
- 3 August 2023
- journal article
- research article
- Vol. 94 (4) , e2023195
Abstract
Hypogonadism and abnormalities of glucose homeostasis, resulting from iron-induced pituitary and pancreatic β-cell dysfunction respectively, are the most frequently reported endocrine abnormalities in patients with ß-thalassemia major (β-TM), also identified as transfusion-dependent thalassemia (TDT). The aim of the present retrospective study was to evaluate the long-term effects of hormone replacement therapy (HRT) on glucose metabolism and insulin secretion/sensitivity during 3-h oral glucose tolerance test (OGTT) in adolescent and young β-TM women with acquired hypogonadototropic -hypogonadism (AHH).Twelve hypogonadal β-TM females with AHH on HRT were followed for 8.26 ± 1.49 years. At baseline, 10 patients (83.3%) had normal OGTT, 1 patient presented with impaired glucose tolerance (IGT) and 1 patient had an isolated PG level of 165 mg/dL at 1-h during OGTT (H-NGT). At last evaluation, 7 patients (58.4 %) had normal OGTT, while 5 patients (41.6%) had abnormal OGTT. Reduced insulin sensitivity and impaired first-phase insulin secretion were also documented. Three of 4 β-TM patients on treatment with estradiol hemihydrate MX 50 patches plus oral medroxyprogesterone acetate (MPA), associated with a very effective iron chelation therapy, maintained normal glucose tolerance from baseline to last evaluation. Significant adverse events due to HRT or additional endocrine complications were not documented in any cases during the follow-up. Deterioration of glycemia (dysglycemia) occurred in 45.4% (5/11) of thalassemic females on long-term HRT. Additional studies are needed to elucidate the validity of our preliminary observations.Keywords
This publication has 32 references indexed in Scilit:
- Patterns of Insulin Concentration During the OGTT Predict the Risk of Type 2 Diabetes in Japanese AmericansDiabetes Care, 2013
- Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelinesIndian Journal of Endocrinology and Metabolism, 2013
- Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled studyBlood, 2012
- Cerebral thrombosis in patients with β-thalassemiaBlood Coagulation & Fibrinolysis, 2012
- Etiology and Treatment of Hypogonadism in AdolescentsPediatric Clinics of North America, 2011
- Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose LevelsDiabetes Care, 2009
- Repaglinide treatment amplifies first‐phase insulin secretion and high‐frequency pulsatile insulin release in Type 2 diabetesDiabetic Medicine, 2005
- Italian cross-sectional growth charts for height, weight and BMI (6–20 y)European Journal of Clinical Nutrition, 2002
- Pharmacokinetics of sex steroids in patients with beta thalassaemia major.Journal of Clinical Pathology, 1993
- Magnetic-Susceptibility Measurement of Human Iron StoresNew England Journal of Medicine, 1982